| Current Price | $32.86 | Mkt Cap | $3.8B |
|---|---|---|---|
| Open | $32.80 | P/E Ratio | -5.06 |
| Prev. Close | $32.86 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $32.37 - $33.17 | Volume | 1,007,293 |
| 52-Wk Range | $20.67 - $62.75 | Avg. Daily Vol. | 2,046,342 |
| Current Price | $32.86 | Mkt Cap | $3.8B |
|---|---|---|---|
| Open | $32.80 | P/E Ratio | -5.06 |
| Prev. Close | $32.86 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $32.37 - $33.17 | Volume | 1,007,293 |
| 52-Wk Range | $20.67 - $62.75 | Avg. Daily Vol. | 2,046,342 |
The best Bull and Bear pitches based on recency and number of recommendations.
Q4 revenue of $32.9 million, up 64%, and FY2018 rev. of $90.6 million, up 82% YoY hints at multibillion opportunity associated with disrupting tissue biopsy genetic discovery. Growing use of liquid biopsy test in solid tumor cancer = FY 2019 revenue… More
Read the most recent pitches from players about GH.
Recs
pjmusser
(< 20)
Submitted: 9/24/2022 9:58:45 AM :
Start Price:
$48.59
NASDAQ:GH Score:
-49.51
Blood screening for cancer will be the new standard of care
Recs
Car12703
(< 20)
Submitted: 1/18/2022 1:19:48 PM :
Start Price:
$73.03
NASDAQ:GH Score:
-49.18
From Zacks or Fidelity January 2022:
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 27.1%
Price/Sales (TTM) = 23.0
Recs
TMFjimhalley
(< 20)
Submitted: 4/21/2021 1:31:43 PM :
Start Price:
$153.34
NASDAQ:GH Score:
-82.17
The company's liquid biopsies are a huge trend and I can see the company possibly being bought out by a larger pharmaceutical company. Plenty of promise and revenue growth but there's risk as well since the company isn't turning a profit.
Find the members with the highest scoring picks in GH.
fusion59102 (74.21) Score: +210.69
The Score Leader is the player with the highest score across all their picks in GH.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| chammond55 | 94.10 | 5/1/2023 |
|
5Y | $21.51 | +53.28% | +3.36% | +49.92 | 0 Comment | |
| PAGEBOY54 | 92.45 | 5/4/2023 |
|
3Y | $23.06 | +42.97% | +5.68% | +37.29 | 0 Comment | |
| Gmoney70 | 46.15 | 4/6/2023 |
|
5Y | $23.63 | +39.53% | +5.72% | +33.80 | 0 Comment | |
| RyanIdaho | 33.95 | 3/23/2023 |
|
5Y | $25.28 | +30.42% | +8.85% | +21.57 | 0 Comment | |
| GoldMiner20 | < 20 | 1/10/2023 |
|
5Y | $27.29 | +20.81% | +11.05% | +9.76 | 0 Comment | |
| bizcbug7 | 62.31 | 2/27/2023 |
|
5Y | $28.93 | +13.96% | +7.55% | +6.42 | 0 Comment | |
| mudflap93 | < 20 | 6/9/2023 |
|
5Y | $32.80 | +0.52% | +0.02% | +0.50 | 0 Comment | |
| funcioneitor | 93.53 | 1/18/2023 |
|
1Y | $32.84 | +0.40% | +7.79% | -7.39 | 0 Comment | |
| Car12703 | < 20 | 1/18/2022 |
|
5Y | $73.03 | -54.85% | -5.68% | -49.18 | 1 Comment | |
| pjmusser | < 20 | 9/26/2022 |
|
3Y | $48.59 | -32.15% | +17.37% | -49.51 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
